tbuckley/cabot-search huggingface dataset:
Abstract 202: Low Mitochondrial Membrane Potential Identified a Novel Population of Human Cardiac Progenitor Cells with the Capacity for Myocardial Repair
Authors: Xiuchun Li, Xiao-Liang Wang, Edward Bennett, Chuanxi Cai
Journal: Circulation Research (2018)

As resident cardiac stem/progenitor cells (CPCs) stay in the hypoxia niche, have less metabolic activity and lower mitochondrial membrane potential, the aim of this study was to characterize a new subset of CPCs with lower mitochondrial membrane potential and examine their potential for myocardial repair. Following the live cell staining with a lipophilic cationic dye tetramethylrhodamine methyl ester (TMRM) at a final concentration of 25 nm, a novel subset of hCPCs with the lowest ~3% TMRM fluorescence were sorted from right atrial appendage derived cells (RAACs) in patients with cardiomyopathy, and named as ΔΨ m low -hCPCs, which are self-renewable, and characterized as positive (&gt;90%) for CD90, CD44, CD140b, CD172a, however, negative (&lt;5%) for CD34, CD45, CD54, CD117, CD133. The increased expression of pluripotent genes (LIN28, NANOG, &amp; OCT3/4) and cardiac lineage genes (GATA4, MEF2C, MYOCD, &amp; NKX2.5), as well as the decreased expression of cell cycle inhibitor (CDKN2A &amp; CDKN1A) were observed in ΔΨ m low -hCPCs comparing with the non-sorted RAACs. Interestingly, ΔΨ m low -hCPCs exclusively express heme oxygenase-1 (HO-1). And CPCs positive for HO-1 and NKX2.5/GATA4 were found in the intact human heart tissue sections. ΔΨ m low -hCPCs are able to differentiate into all three cardiac lineage cells in both in vitro and in vivo conditions, and display superior ability for survival, proliferation and release of cytoprotective cytokines compared to the RAACs. At 35 days, compared with the vehicle and control cell groups, transplantation of ΔΨ m low -hCPCs significantly improve the cardiac structure and function following myocardial infarction in the immunodeficient mouse model, as indicated by the increased left ventricular (LV) ejection fraction, increased positive and negative LV dP/dt, reduced LV remodeling, and reduced infarct size. The immunohistochemistry studies showed the significant increased cardiac proliferation, newly formed cardiomyocytes, angiogenesis, and decreased cell apoptosis in the ΔΨ m low -hCPCs treated group. In summary, we identified a new hCPC population that might represent a primitive progenitor cell population within human hearts. The existence of these cells opens new opportunities for myocardial repair.
A FIRST-IN-HUMAN STUDY OF THE SECOND-GENERATION, THIN-STRUT, EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLD: 6-MONTH IVUS AND OCT RESULTS FROM THE FAST CLINICAL TRIAL
Authors: Ryo Kameda, Kozo Okada, Masayasu Ikutomi, M. Brooke Hollak, Paul Yock, Jeffrey Popma, Sujith Seneviratne, Andrejs Erglis, Darren Walters, Robert Whitbourn, Jamie Layland, Jim Stewart, Seif El-Jack, Thomas Christen, Ian Meredith, Peter Fitzgerald, Yasuhiro Honda
Journal: Journal of the American College of Cardiology (2019)
GENOTYPE AND CLINICAL CHARACTERISTICS OF CONGENITAL LONG QT SYNDROME IN CHINA: A CHINESE SINGLE CENTER STUDY
Authors: Kun Li, Yang Jing, Yuanwei Liu, He Rong, Xue Yajun, She Fei, Liu Fang, Miao Guobin, Lv Tingting, Qiao Yu, Sun Shenjie, Li Siyuan, Zhou Jie, Li Ling, Zhang Ping
Journal: Journal of the American College of Cardiology (2019)
TRANSEOPHAGEAL ECHOCARDIOGRAPHY COMPLICATIONS ASSOCIATED WITH INTERVENTIONAL CARDIOLOGY PROCEDURES
Authors: Afonso Freitas-Ferraz, Josep Rodes-Cabau, Lucia Junquera, Jonathan Beaudoin, Kim O'Connor, Jean-Michel Paradis, Alfredo Ferreira-Neto, Lluis Asmarats, Mathieu Bernier
Journal: Journal of the American College of Cardiology (2019)
Abstract 457: Ca2+/calmodulin Dependent Kinase II Exacerbates Heart Failure Progression Through Activation of Class I Histone Deacetylases
Authors: Manling Zhang, Elizabeth D Luczak, Jonathan Granger, Joan H Brown, Mark E Anderson, Ning Feng
Journal: Circulation Research (2018)

Background: Persistent cardiac Ca2+/calmodulin dependent Kinase II (CaMKII) activation in patients receiving standard heart failure therapies, appears to play an essential role in heart failure development. The molecular mechanisms of CaMKII induced heart failure progression remains incompletely understood and new mechanism based therapeutic strategies are warranted. Histone deacetylases (HDACs) are critical for transcriptional genes reprogramming leading to adverse ventricular remodeling. Class I HDACs, including HDAC 1, HDAC2 and HDAC3, promote pathological cardiac hypertrophy, whereas class IIa HDACs suppress cardiac hypertrophy. It is known that CaMKII deactivates class IIa HDACs to enhance cardiac hypertrophy, however, it is unknown whether CaMKII also regulates class I HDACs in heart failure development. Results: We found that CaMKII directly phosphorylates recombinant HDAC1 protein and increases its deacetylase activity by three-fold. HDAC1 activity is also increased in cardiac specific CaMKII over-expressing transgenic mice (CaMKII-TG). Mass spectrometry reveals HDAC1 is a CaMKII substrate. Beyond direct phosphorylation, CaMKII also increases HDAC1 expression. In cultured neonatal rat cardiac myocytes, overexpression of CaMKII markedly increases HDAC1 expression, and this CaMKII induced HDAC1 upregulation is mediated through JNK pathway, as JNK inhibitor SP600125 blunts this upregulation. HDAC1 expression is significantly increased in vivo, in CaMKII-TG mice. Consistently, the expression of HDAC1 is increased in failing hearts from wild type mice after myocardial infarction surgery, and this upregulation is attenuated in transgenic mice with myocardial expression of AC3-I, a CaMKII inhibitory peptide. Importantly, an HDAC1 specific inhibitor Quisinostat prevents or improves CaMKII overexpression induced cardiac hypertrophy and heart failure progression in vitro and in vivo. In addition, CaMKII also increases deacetylase activity and expression of other Class I HDACs, HDAC2 and HDAC3. Conclusion: CaMKII activates class I HDACs in heart failure, which may be a central mechanism for heart failure progression.
SEX AND GENDER DIFFERENCES IN ZIKA MYOCARDITIS
Authors: Karina Gonzalez Carta, Ivan J. Mendoza Britto, Yolimar Meza, Igor Morr, Juan Marques, Vicente Finizola Flores, Thomas Allison, Francisco Lopez-Jimenez, Carmen Terzic, Ivan Mendoza
Journal: Journal of the American College of Cardiology (2019)
AN AORTIC VALVE REPLACEMENT SCREEN THAT STANDS UP TO THE TASK: COMPARING FIDELITY OF CHAIR RISE SCREENING, SOCIETY OF THORACIC SURGEONS SCORE AND AMERICAN COLLEGE OF CARDIOLOGY TRANSCATHETER AORTIC VALVE REPLACEMENT IN-HOSPITAL MORTALITY RISK SCORE TO PREDICT POOR OUTCOMES AND FUNCTIONAL TRAJECTORIES IN OLDER PATIENTS
Authors: Anthony Maltagliati, Dae Hyun Kim
Journal: Journal of the American College of Cardiology (2019)
Patient-Tailored, Connectivity-Based Forecasts of Spreading Brain Atrophy
Authors: Jesse A. Brown, Jersey Deng, John Neuhaus, Isabel J. Sible, Ana C. Sias, Suzee E. Lee, John Kornak, Gabe A. Marx, Anna M. Karydas, Salvatore Spina, Lea T. Grinberg, Giovanni Coppola, Dan H. Geschwind, Joel H. Kramer, Maria Luisa Gorno-Tempini, Bruce L. Miller, Howard J. Rosen, William W. Seeley
Journal: Neuron (2019)
Ulcerative colitis-specific delivery of keratinocyte growth factor by neutrophils-simulated liposomes facilitates the morphologic and functional recovery of the damaged colon through alleviating the inflammation
Authors: Ying-Zheng Zhao, De-Li ZhuGe, Meng-Qi Tong, Meng-Ting Lin, Ya-Wen Zheng, Xue Jiang, Wai-Geng Yang, Qing Yao, Qi Xiang, Xiao-Kun Li, He-Lin Xu
Journal: Journal of Controlled Release (2019)
Longitudinal Mutational Analysis in Hydroxycarbamide-Resistant/Intolerant Essential Thrombocythemia Treated on the Majic-ET Study
Authors: Jennifer O'Sullivan, Angela Hamblin, Anesh Panchal, Christina Yap, Sonia Fox, Samah Alimam, Helene Marie-Pierre Dreau, Kieran Howard, Pauline Ware, Samantha Baker, Nicholas C.P. Cross, Mary Frances McMullin, Claire N. Harrison, Adam J. Mead
Journal: Blood (2018)
Target Population, Dose, and Timing Considerations for Understanding Naltrexone’s Subjective Effect: Response to Amiaz
Authors: Boris D. Heifets, Nolan R. Williams, Christine Blasey, Keith Sudheimer, Carolyn I. Rodriguez, Alan F. Schatzberg
Journal: American Journal of Psychiatry (2019)

naltrexone or placebo and intravenous ketamine.Because all patients received ketamine, the effect of adding naltrexone without ketamine was not tested.Specifically, the risk of naltrexone exacerbating symptoms in this population was ignored.Studies concerning the combination of antidepressants and naltrexone in a population of abstinent alcoholicdepressive patients who were already taking naltrexone show that the addition of SSRIs had no additional effect (2, 3).It has been claimed that one of the main side effects of naltrexone in this population is depression (4, 5).The effect of naltrexone on mood in a population without a history of substance abuse is not fully established.Lowdose naltrexone as an add-on treatment may improve depression in patients with fibromyalgia (6, 7), while a higher dose of naltrexone in combination with SSRIs might exacerbate depressive symptoms (8).Nevertheless, this work raises many interesting questions concerning the involvement of the opiate system in the treatment of depression.It would be interesting to further investigate whether opiate antagonists can attenuate the effect of other antidepressant treatments (e.g., ECT).
With Equal Access and Utilization of Resources,Younger African American Patients Have Superior Survival Compared to Caucasian Patients Diagnosed with Multiple Myeloma at the Veterans Affairs Hospitals
Authors: Nathanael Fillmore, Sarvari Venkata Yellapragada, Mehmet Kemal Samur, Gustavo A. Rivero, Saiju Pyarajan, Nhan Do, Mary Brophy, Nikhil Munshi
Journal: Blood (2018)
THE ADVANTAGE OF PACLITAXEL-ELUTING STENT IMPLANTATION FOR FEMOROPOPLITEAL LESIONS
Authors: Masakazu Tsutsumi, Yoshiaki Ito, Keisuke Hirano, Masahiro Yamawaki, Motoharu Araki, Norihiro Kobayashi
Journal: Journal of the American College of Cardiology (2019)
CHARACTERISTICS OF AF PATIENTS WITH LARGE IMPROVEMENT IN SYMPTOMS AT ONE YEAR: SUPER-RESPONSE IN THE ORBIT-AF REGISTRY
Authors: Benjamin Adam Steinberg, DaJuanicia Holmes, Karen Pieper, Paul Chan, Gregg Fonarow, James Freeman, Larry Allen, Elaine Hylek, Michael Ezekowitz, Peter Kowey, Daniel Singer, Bernard Gersh, Kenneth Mahaffey, Gerald Naccarelli, James Reiffel, Eric Peterson, Jonathan Piccini
Journal: Journal of the American College of Cardiology (2019)
PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia
Authors: Lorenz Bastian, Michael P. Schroeder, Cornelia Eckert, Cornelia Schlee, Jutta Ortiz Tanchez, Sebastian Kämpf, Dimitrios L. Wagner, Veronika Schulze, Konstandina Isaakidis, Juan Lázaro-Navarro, Sonja Hänzelmann, Alva Rani James, Arif Ekici, Thomas Burmeister, Stefan Schwartz, Martin Schrappe, Martin Horstmann, Sebastian Vosberg, Stefan Krebs, Helmut Blum, Jochen Hecht, Philipp A. Greif, Michael A. Rieger, Monika Brüggemann, Nicola Gökbuget, Martin Neumann, Claudia D. Baldus
Journal: Leukemia (2019)
Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy
Authors: Min Luo, Zhida Liu, Xinyi Zhang, Chuanhui Han, Layla Z. Samandi, Chunbo Dong, Baran D. Sumer, Jayanthi Lea, Yang-Xin Fu, Jinming Gao
Journal: Journal of Controlled Release (2019)
Measles: alarming worldwide surge seriously threatens children, says UN
Authors: Owen Dyer
Journal: BMJ (2019)

The number of measles cases around the world jumped by 48.4% last year and is still climbing quickly, the UN children’s agency Unicef has warned, blaming the rise on inadequate vaccine coverage caused partly by misinformation.

“This is a wake-up call,” said Henrietta Fore, Unicef’s executive director. “We have a safe, effective, and inexpensive vaccine against a highly contagious disease—a vaccine that has saved almost a million lives every year over the past two decades.

“These cases haven’t happened overnight. Just as the serious outbreaks we are seeing today took hold in 2018, lack of action today will have disastrous consequences for children tomorrow.”

Some 98 countries saw a rise in measles cases in 2017-18, said Unicef, with 10 countries accounting for 74% of the increase. Ukraine, the Philippines, and Brazil saw the biggest jumps in …
RISK PREDICTION MODEL FOR PERMANENT PACEMAKER IMPLANTATION AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION: A SINGLE HIGH VOLUME CENTER EXPERIENCE
Authors: Takahiro Tsushima, Fahd Nadeem, Sadeer Al-Kindi, Joshua Clevenger, Eric Bansal, Ankur Kalra, Guilherme Attizzani, Judith Mackall, Marco Costa, Daniel Simon, Mauricio Arruda, Sergio Thal
Journal: Journal of the American College of Cardiology (2019)
Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier
Authors: Sophie Nyberg, N. Joan Abbott, Xiaorui Shi, Peter S. Steyger, Alain Dabdoub
Journal: Science Translational Medicine (2019)

Permanent hearing loss affects more than 5% of the world's population, yet there are no nondevice therapies that can protect or restore hearing. Delivery of therapeutics to the cochlea and vestibular system of the inner ear is complicated by their inaccessible location. Drug delivery to the inner ear via the vasculature is an attractive noninvasive strategy, yet the blood-labyrinth barrier at the luminal surface of inner ear capillaries restricts entry of most blood-borne compounds into inner ear tissues. Here, we compare the blood-labyrinth barrier to the blood-brain barrier, discuss invasive intratympanic and intracochlear drug delivery methods, and evaluate noninvasive strategies for drug delivery to the inner ear.
Abstract 465: Short Term Hypoxia Can Induce Adult Feline Cardiomyocytes to Re-enter the Cell Cycle and Divide
Authors: Jaslyn Johnson, Polina Gross, Remus Berretta, Hajime Kubo, Sadia Mohsin, Steven R Houser
Journal: Circulation Research (2018)

Rationale: The mammalian adult heart has a very limited capacity to regenerate cardiomyocytes that die from pathological damage. Most recent studies suggest that those few new myocytes found after injury are derived from pre-existing cardiomyocytes. A recent study in mice suggest that systemic hypoxemia in adult animals can induce cardiac myocyte cell cycle reentry and myocyte proliferation. In the present experiments we evaluate the ability of adult feline cardiomyocytes to reenter the cell cycle and proliferate in hypoxic environments. Hypothesis: To determine if hypoxia induces adult feline cardiomyocytes to regenerate. Methods and results: Adult ventricular cardiomyocytes were isolated from adult felines and maintained in culture. For acute hypoxia, cultures were placed in a hypoxic chamber on day 1, 3, 5, 7, 10, or 14 following isolation and subjected to 1% O 2 , 5% CO 2 , and the balance was N 2 for 24 hours. For chronic hypoxia, adult cardiomyocytes were subjected to 1% O 2 , 5% CO 2 with the balance of N 2 at day 1 after isolation and kept at continuous hypoxia for 3, 5, 7, 10, or 14 days. Prior to hypoxia, cells were treated with 10uM EdU to identify new DNA in cardiomyocytes. Acute hypoxia was shown to promote cell division in cardiac myocytes at all time points except at day 1 post isolation when compared to control cultures. However, chronic hypoxia caused cardiomyocyte damage and increased cell death in all time points as compared to control and acute hypoxia cultures. Conclusion: Short term hypoxia can induce adult feline cardiomyocytes to proliferate, while long term exposure leads to injury and apoptosis.
Abstract 565: Coxsackievirus Infection During the First Trimester of Pregnancy Suppresses Cardiomyocyte Proliferation Leading to Congenital Heart Defects
Authors: Vipul Sharma, Lisa Goessling, Sara Rohrbough, Anoop Brar, Pirooz Eghtesady
Journal: Circulation Research (2018)

Purpose: Coxsackievirus B (CVB), known to be the most common cause of myocarditis, target cardiomyocytes through Coxsackie and Adenovirus Receptor, which is highly expressed in the fetal heart. We hypothesized that CVB infection during early pregnancy may play a role in the pathogenesis of congenital heart disease (CHD). Methods: Pregnant C57Bl/6J mice were infected with varying doses of CVB3 (Nancy strain), 1x10 6 , 2.5x10 6 , and 5x10 6 TCID50, between embryonic days (E) 5-11. Presence of the virus was confirmed by RT-PCR and infectivity assay. Fetal heart phenotype was assessed by histology. RNA collected from fetal hearts using laser microdissection was analyzed by RNA-Seq to understand changes at the molecular level after infection. Results were confirmed by immunohistochemistry and qPCR. To determine if virus serotype alters the outcome, CVB1, CVB4, and a combination of CVB3 and CVB4 were used for infection. To assess the clinical significance serum from pregnant human subjects, grouped based on outcome of pregnancy (healthy baby vs babies with CHD), was checked for the presence of CVB serotypes. Results: Fetuses developed spectrum of CHD (38.2%, n=78/204): ventricular septal defect, double outlet right ventricle, and non-compaction of ventricular myocardium after CVB3 infection. Approximately one third of the fetuses were resorbed (38.7%, n=129/333). Infection at E9 led to the highest incidence of VSD with female fetuses being more susceptible to the phenotype. Transcripts found to be differentially expressed in hearts with VSDs were mediators of the Transforming growth factor β and Extracellular matrix signaling pathways. Consistent with the former, expression levels of BMP2 and Smad1/5/9 mRNA were elevated in fetal hearts with VSDs. This correlated with suppressed proliferation of cardiomyocytes in these mice. In pregnant human subjects who had babies with CHD elevated titers of antibodies against CVB3, CVB4, and CVB3+CVB4 were seen. In mice, infection with CVB1, CVB4, or CVB3+4 showed that CVB3 in combination with CVB4 induces more VSDs than infection with any one serotype. Conclusion: There is a critical window during pregnancy where CVB infection leads to abnormal cardiac development likely through reduction of cardiomyocyte proliferation.
DOES RESTING CARDIAC POWER EFFICIENCY AFFECT SURVIVAL POST TRANSCATHETER AORTIC VALVE REPLACEMENT?
Authors: Pradyumna Agasthi, Reza Arsanjani, Floyd Fortuin, Panwen Wang, Justin Lee, Nithin R. Venepally, John Sweeney, Mackram Eleid, Peter Pollak, Farouk Mookadam
Journal: Journal of the American College of Cardiology (2019)
CX3CL1–CX3CR1 interaction mediates macrophage-mesothelial cross talk and promotes peritoneal fibrosis
Authors: Alexandra Helmke, Johannes Nordlohne, Michael S. Balzer, Lei Dong, Song Rong, Marcus Hiss, Nelli Shushakova, Hermann Haller, Sibylle von Vietinghoff
Journal: Kidney International (2019)
PERCUTANEOUS TRANSVALVULAR MICROAXIAL VENTRICULAR ASSIST DEVICE TO DECOMPRESS THE LEFT VENTRICLE IN PATIENTS UNDERGOING VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION FOR CARDIOGENIC SHOCK: A SYSTEMATIC REVIEW AND METANALYSIS
Authors: Edwin Grajeda, Jesus Pino, Waqas Ghumman
Journal: Journal of the American College of Cardiology (2019)
Identification of Individualized Minimal Residual Disease in Acute Myeloid Leukemia By Flow Cytometry and Its Application of Prognostic Significance
Authors: Jing-Ni Sui, Qiu-Sheng Chen, Yun-Xiang Zhang, Yan Sheng, Jing Wu, Jun-Min Li, Jiong Hu, Xiang-Qin Weng, Bing Chen
Journal: Blood (2018)
OUTCOMES OF SAVR VERSUS TAVR IN AORTIC STENOSIS HOSPITALIZATIONS WITH ANGIODYSPLASIA-ASSOCIATED GASTROINTESTINAL BLEEDING (HEYDE'S SYNDROME): INSIGHTS FROM A NATIONWIDE PROPENSITY-MATCHED ANALYSIS
Authors: Rupak Desai, Sonu Gupta, Sandeep Singh, Rushikkumar Bhuva, Dipen Zalavadia, Tarang Parekh, Upenkumar Patel, Manan Vyas, Hemant Goyal, Gautam Kumar, Rajesh Sachdeva
Journal: Journal of the American College of Cardiology (2019)
PPP1R12C REGULATES MYOCARDIAL CONTRACTILITY THROUGH DEPHOSPHORYLATION OF ATRIAL MYOSIN LIGHT CHAIN
Authors: Srikanth Perike, Katherina Alsina, Arvind Sridhar, Andrielle Capote, Jody Marin, Beata Wolska, Xander Wehrens, Dawood Darbar, Mark McCauley
Journal: Journal of the American College of Cardiology (2019)
SWITCHING FROM RAMIPRIL TO SACUBITRIL/VALSARTAN FAVORABLY ALTERS ELECTROCARDIOGRAPHIC INDICES OF VENTRICULAR REPOLARIZATION IN HEART FAILURE WITH REDUCED EJECTION FRACTION
Authors: Sercan Okutucu, Cengiz Sabanoglu, Begum Yetis, Hakan Aksoy, Nurbanu Bursa, Ali Oto
Journal: Journal of the American College of Cardiology (2019)
ROLE OF WINGLESS-REGULATORY MOLECULES DICKKOPF-RELATED PROTEIN 1 AND PODOCAN ON LEFT VENTRICULAR REMODELING IN PATIENTS WITH AORTIC STENOSIS
Authors: Kanjit Leungsuwan, Saeeda Fatima, Abdullah Shahid, Jennifer Victory, Harish Raj Seetha Rammohan, Melissa Scribani, Paul Jenkins, Deborah Hyink, Paul Klotman, Randolph Hutter, Daniel Katz
Journal: Journal of the American College of Cardiology (2019)
A NEW, SIMPLE ECG ALGORITHM FOR THE RAPID IDENTIFICATION OF VENTRICULAR TACHYCARDIA BASED ON OPPOSING QRS COMPLEXES ON LIMB LEADS
Authors: Qiong Chen, Sanghamitra Mohanty, Domenico Della Rocca, Chintan Trivedi, Carola Gianni, Alfredo Tapia, Omer Gedikli, Andrea Natale, Jinyi Xu
Journal: Journal of the American College of Cardiology (2019)
DONOR PATIENTS ON VASOACTIVE MEDICATIONS DOES NOT IMPACT SURVIVAL FOR HEART TRANSPLANT RECIPIENTS BASED ON THE UNITED NETWORK FOR ORGAN SHARING (UNOS) DATABASE
Authors: Ramola Panchal, Kristen Carter, Seth Lirette, Anthony Panos, Richard Cochran, Lawrence Creswell, David Baran, Hannah Copeland
Journal: Journal of the American College of Cardiology (2019)
GLOBAL LONGITUDINAL STRAIN AS AN INCREMENTAL PROGNOSTIC VALUE IN PATIENTS WITH PRESERVED EJECTION FRACTION UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT
Authors: Dae-Hee Kim, Sunhack Lee, Seung-Ah Lee, Do-Yoon Kang, Sahmin Lee, Jung-Min Ahn, Duk-Woo Park, Jong-Min Song, Duk-Hyun Kang, Jae-Kwan Song, Seung-Jung Park
Journal: Journal of the American College of Cardiology (2019)